Strain Analysis as a Right Ventricle Contractility Marker
1 other identifier
interventional
16
1 country
2
Brief Summary
The analysis of the systolic function (contractility) of the right ventricle (RV) is fundamental and central in many pathologies in intensive care unit. It can guide physicians in choosing therapeutics. The conventional ultrasound markers of RV function evaluation currently used are influenced by RV loading conditions, impairing their capacity to approximate a true contractility analysis. Myocardial strain imaging is a recent echographic technique that allows, among other things, to evaluate RV systolic function. It is a reproducible index with early variations which, if it proved to be independent pre-load, would help to better appreciate the RV contractility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2016
CompletedFirst Submitted
Initial submission to the registry
March 10, 2017
CompletedFirst Posted
Study publicly available on registry
March 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedOctober 31, 2019
October 1, 2019
1.1 years
March 10, 2017
October 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the change in the Longitudinal strain of the free wall right ventricle
measurements will be performed using an ultrasound device usually used in our center for the hemodynamic monitoring of patients in intensive care by transthoracic cardiac ultrasound
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Secondary Outcomes (9)
Evaluation of the change in S' right ventricle wave
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in tricuspid annular plane systolic excursion (TAPSE)
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in visual left ventricular ejection fraction (LVEF)
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in mitral E wave
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
Evaluation of the change in mitral A wave
at baseline, 1 minute after starting hemodialysis, 1 hour after, and 5 minutes before restitution
- +4 more secondary outcomes
Study Arms (1)
ultrasound measurements
OTHERultrasound measurements of myocardial deformation of free wall right ventricle during a sharp decline of right ventricle preload induced during a session of Intermittent hemodialysis.
Interventions
ultrasound measurements of myocardial deformation of free wall right ventricle at 4 time points during a session of intermittent hemodialysis : before the intermittent hemodialysis connection, just after starting hemodialysis, after 1 hour of hemodialysis and 5 minutes before restitution
Eligibility Criteria
You may qualify if:
- Male or female ≥ 18 years
- Patients with renal failure treated with intermittent hemodialysis
You may not qualify if:
- Patients with heart disease (valvular, ischemic, rhythmic)
- Patients with ejection fraction of left ventricular altered \<45%
- Chronic dialysis patients
- Patients referred in Articles L. 1121-5, L.1121-6, L.1121-7, L.1121-8 of the Public Health Code:
- Pregnant women, parturients or nursing mothers
- Persons deprived of their liberty by a judicial or administrative decision, persons subject to psychiatric care, persons admitted to a health or social institution for purposes other than research
- Minor Patients
- Major persons who are subject to a legal protection measure or are unable to express their consent
- Patients not willing to participate in the study
- Patients not affiliated to a social security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital de la Croix Rousse
Lyon, 69004, France
Hopital Saint Joseph Saint Luc
Lyon, 69007, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zoé Schmitt
Hôpital de la Croix-Rousse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2017
First Posted
March 24, 2017
Study Start
November 25, 2016
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
October 31, 2019
Record last verified: 2019-10